$33.08
+0.36 (+1.10%)
Open$32.79
Previous Close$32.72
Day High$33.60
Day Low$32.42
52W High$40.22
52W Low$8.51
Volume—
Avg Volume445.0K
Market Cap2.04B
P/E Ratio—
EPS$-0.13
SectorBiotechnology
Analyst Ratings
Strong Buy
18 analysts
Price Target
+51.7% upside
Current
$33.08
$33.08
Target
$50.17
$50.17
$29.72
$50.17 avg
$68.67
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 192.22M | 323.22M | 315.22M |
| Net Income | -7,178,637 | -37,471,003 | -43,595,472 |
| Profit Margin | -3.7% | -11.6% | -13.8% |
| EBITDA | -19,671,813 | -52,091,948 | -53,358,586 |
| Free Cash Flow | — | -52,998,459 | -42,607,892 |
| Rev Growth | +145.9% | +14.4% | -1.8% |
| Debt/Equity | — | 0.58 | 0.65 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |